Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microvascular circulation encompasses the movement of blood within the smallest vessels (arterioles, capillaries, venules) of an organ’s microvasculature. This system is essential for delivering oxygen and nutrients, removing metabolic waste, regulating vascular resistance, and maintaining tissue homeostasis. Microcirculatory dysfunction contributes to various clinical syndromes, particularly cardiovascular diseases, via mechanisms such as microvascular spasm, impaired perfusion, increased endothelial permeability, glycocalyx degradation, and inflammatory cell plugging. Therapeutic strategies typically target the underlying pathophysiology at the level of endothelial cells, smooth muscle cells, or mediators regulating vascular tone and immune responses rather than the microvascular circulation itself.
Improving microvascular perfusion through vasodilation (e.g., nitric oxide donors) Reducing platelet and leukocyte adhesion (antiplatelet and anticoagulant drugs) Protecting the endothelial barrier/glycocalyx Modulating signaling pathways involved in vascular tone (e.g., inhibition of angiotensin II receptor)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microvascular circulation.